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Abstract
To identify novel biomarkers for HIV-1 resistance, including pathways that may be critical in anti-HIV-1 vaccine design, we
carried out a gene expression analysis on blood samples obtained from HIV-1 highly exposed seronegatives (HESN) from a
commercial sex worker cohort in Nairobi and compared their profiles to HIV-1 negative controls. Whole blood samples were
collected from 43 HIV-1 resistant sex workers and a similar number of controls. Total RNA was extracted and hybridized to
the Affymetrix HUG 133 Plus 2.0 micro arrays (Affymetrix, Santa Clara CA). Output data was analysed through ArrayAssist
software (Agilent, San Jose CA). More than 2,274 probe sets were differentially expressed in the HESN as compared to the
control group (fold change $1.3; p value #0.0001, FDR ,0.05). Unsupervised hierarchical clustering of the differentially
expressed genes readily distinguished HESNs from controls. Pathway analysis through the KEGG signaling database revealed
a majority of the impacted pathways (13 of 15, 87%) had genes that were significantly down regulated. The most down
expressed pathways were glycolysis/gluconeogenesis, pentose phosphate, phosphatidyl inositol, natural killer cell
cytotoxicity and T-cell receptor signaling. Ribosomal protein synthesis and tight junction genes were up regulated. We
infer that the hallmark of HIV-1 resistance is down regulation of genes in key signaling pathways that HIV-1 depends on for
infection.
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Introduction
The disease AIDS perhaps ranks as one of the most devastating
scourges of mankind. Since it was identified in 1983 more than 30
million people have died and another 33 million currently live with
the virus [1,2]. The majority of HIV-1 infections occur in Sub-
Saharan Africa, where in some countries prevalence rates of more
than 40% have been documented among antenatal clinic
attendees [3]. Despite advances made in antiretroviral therapy,
only a third of those requiring treatment receive it and new
infections far outstrip those on therapy [4]. Similar to other
previous viral epidemics, prevention through vaccination shall be
the best approach. However, the nature of the AIDS virus to
integrate itself to the host genome and its ability to constantly
mutate and shield immunogenic components that induce protec-
tive antibodies, continue to pose challenges for an effective
vaccine. Though a recent prime boost vaccine strategy, RV 144,
provided signals that a HIV-1 vaccine was possible, its efficacy was
only a modest 30% [5].
The presence of individuals who are highly exposed to HIV-1
but do not get infected, provide hope for a better understanding of
correlates for protection that may lead to a more effective vaccine
strategy. Highly exposed seronegative (HESN) populations have
been identified among intravenous drug users [6], children born to
seropositive mothers [7,8], discordant couples [9,10], and
commercial sex workers [11–13]. The findings in 1996 on the
protective effect of the CCR5D32 allele in HIV-1 infection [14]
shifted focus to host genetics as probable cause of HIV-1
resistance. Over the past 10 years, approximately 40 genes have
been documented from HESN populations as possible candidates
for differential host susceptibility to HIV-1 [15]. This include
selected human leukocyte antigens, HLA [16], TRIM5a [17],
specific KIR-HLA associations [18], and APOBEC3G [19].
However, only a fraction of HESN has the protective genotypes
described in the literature. Previous gene discovery studies have
focused on single gene approaches which may have missed other
compelling gene candidates and overlook interactions between
different genes or genetic pathways. Microarray expression
profiling provides new opportunities for simultaneous analysis of
thousands of messenger RNA expression patterns in tandem with
their biological functions. Less data exist on the use of microarrays
to identify biomarkers for HIV-1 susceptibility, including pathways
that may be critical for successful anti-HIV-1 vaccine and
therapeutic design. In a bid to determine biomarkers and genetic
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30048pathways that are unique to HESNs, we carried out a global whole
blood gene expression profiling of HIV-1 highly exposed and
uninfected individuals from a well-characterized female commer-
cial sex worker cohort from Nairobi, Kenya.
Results
Gene expression outcome
Our primary objective was to investigate if there is a predictive
gene expression pattern that defines the HESN phenotype. Gene
expression data from the 86 micro arrays were normalized and all
were included in the analysis. An unsupervised hierarchical
clustering algorithm was run on the data to ascertain if the two
populations could be separated into two distinct groups based on
their gene expression profiles. Figure 1 show a distinct separation
between the HESN (Test) and HIV negative controls (Controls).
Of the 54675 gene probe setsrepresented on the Affymetrix U133
plus 2.0 gene chip, 2,274 probe sets were differentially expressed in
the HESN group as compared with the control group (fold change
$1.3; p value #0.05) after correction with multiple testing using the
Benjamin-Hochberg false discovery rate (FDR,0.05). Of the total
differentially expressed transcripts, 462 (20%) could be mapped onto
the KEGG signaling database. Figure 2 shows the 15 signaling
events with the highest number of genes identified through the
KEGG analysis. Majority of these pathways (13 of 15, 87%) were
significantly down-regulated in the HESN group. The top ranked
down-regulated pathways belonged to energy metabolism, cell
adhesion, signal transduction and immune signaling categories.
Glucose/gluconeogenesis and pentose phosphate phosphorylation
(p,0.0003) were the most down-regulated metabolic pathways,
together with the immune signaling events of natural killer cell
cytotoxicity (p,0.008), antigen processing and presentation
(p,0.0013) and T-cell receptor signaling. The key up-regulated
pathways were the ribosome protein synthesis and tight junction.
Figures 3 (a to g) show the heatmaps of representative genes in the
significantly impacted pathways. Gene ontology (GO) classification
ofthe differentiallyexpressed transcripts identifiedproteinbindingas
the major functional group among the down-regulated genes
(Fig.4a).Incontrast,up-regulatedgenes weresignificantlyassociated
with nuclear binding (Fig. 4b).
Figure 1. Heatmap of representative genes from a sample of HIV-1 highly exposed uninfected sex workers (Test) and susceptible
HIV negative controls (control) evaluated through unsupervised hierarchical clustering algorithm. Each row on the Y axis represents a
single gene probe and the phylograms represent distinct signaling pathways. The red color denotes up regulated genes while the green are down
regulated.
doi:10.1371/journal.pone.0030048.g001
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More than 40% of genes that had earlier been reported to be
associated with HIV-1 susceptibility in HESN populations were
found to be differentially expressed in this dataset (Table 1). More
significantly, genes that had been observed to be associated with
the resistance phenotype in this cohort through single gene studies
were confirmed to be differentially regulated. This included the
Human leukocyte antigen (HLA) cluster (HLA-A, down-regulated,
p value ,0.001), Killer Immunoglobulin Receptors (KIR3DL1,
down-regulated, p value ,0.001) and Serpin B family (SerpinB13
up-regulated p,0.02). As noted in a previous study [20],
expression of the CCR5 receptor cluster was not statistically
different between the two populations (p value 0.6).
Table 2 shows the list of the top 50 genes identified as
differentially expressed with a fold change of 2 and above. This is
the first time many of these genes have been shown to be
associated with a HESN population.
Quantitative RT-PCR validation
To validate the outcome of the microarray, representative
down-regulated and up-regulated genes were picked for quanti-
tative real time RT-PCR. Genes from one of the most down
regulated signaling pathways- glucose\gluconeogenesis were
randomly picked for qRTPCR analysis while a random sample
of zinc finger proteins were selected to represent upregulated
pathways. And to control for probable effect of sex work, samples
from HIV seronegative sex workers (New Negatives) who had
been involved in sex work for one year or less, were included in the
qRTPCR analysis.
The expression differences of the selected genes in HESN
women as compared to the controls were similar to the microarray
data (Fig. 5). No significant differences were observed in expression
of the validated genes between the HIV seronegative sex workers
and the HIV negative maternal-child health clinic attendees.
Discussion
Our primary objective in this study was to investigate if there is a
predictive gene expression signature pattern that defines the HESN
phenotype in the Pumwani sex worker cohort. Apart from
identifying candidate gene biomarkers, we used a systems biology
approach to take into account the inherent complexity that may not
be elucidated through single gene observations. We also used whole
blood in an attempt to unravel the probable interplay between
systemic intercellular networks that may be lost through individual
cell type approaches. As controlling for HESN studies is often a
challenge, we have attempted to include data from HIV negative
new entrants into the sex worker trade as an additional control
group to lessen confounding factors such as frequent exposures to
other sexually transmitted infections. The overall outcome show a
distinct difference in expression patterns between the HESN
population and controls. Previous studies in this cohort have
identified specific human leukocyte antigens (HLA) and interferon
regulatory factors (IRF) as associated with resistance [16,20,21]. At
the mucosal level, specific antibody responses as well as several
antiproteases have been found to be elevated among the HIV-1
resistant women as compared to the controls [22,23]. We noted a
significantly differential expression pattern on the HLA types,
confirming a probable role these markers may have on HIV-1
resistance. We also observed that some biomarkers, which had been
identified in other HESN populations as possible contributors to the
resistance phenotype, for example defensin b 1 [15] and certain
polymorphs of cyclophilin A [24] were significantly up-regulated in
our HESN group. These associations with previous findings
reinforced our confidence in the platform we used.
Figure 2. Proportion of differentially expressed genes in significantly affected pathways.
doi:10.1371/journal.pone.0030048.g002
Immune Quiescence Predicts HIV Resistance
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30048The most up-regulated gene was the Dipeptidyl peptidase 4
(DPP4). The HESN group had a more than a 2 fold change over
expression of this gene as compared to controls. DPP4, also known as
CD26, is a 110 kDa protein that has been found to be one of the most
ubiquitous soluble proteins. Its expression levels have been associated
with cancer, diabetes and infectious disease [25–27]. The role of
DPP4 in HIV-1 infection remains controversial. One of its known
functions is to cleave dipeptides from the amino terminus of proteins
containing a proline or alanine moiety at the ultimate position. A
number ofchemokines have this sequence attheir termini. RANTES,
a chemokine of the interleukin-8 superfamily, is a selective attractant
for memory T lymphocytes and monocytes and has been shown to
inhibit HIV infection by competitively binding CCR5 [28]. Proost et
al [29] showed that truncated RANTES inhibited HIV-1 infection of
mononuclear cells 5-fold more efficiently than intact RANTES. He
confirmed that the truncation of RANTES was a result of the activity
of DPP4 cleavage. Similarly, Morimoto and co-workers [30] have
demonstrated that Jurkat T cell line expressing very high levels of
DPP4 activity were resistant to HIV-1 infection. In contrast, several
laboratories [31,32] have reported a selective decrease in DPP4-
expressing T cells in AIDS progression, suggesting that DPP4
rendered the cells more sensitive to HIV-1 infection. Our in vivo
observations of clustering of high DPP4 expression among the HESN
sex workers denote a possible HIV-1 protective effect.
Figure 3. Heatmaps of the most differentially regulated signaling pathways among the HIV -1 highly exposed (Test) and HIV
negatives (Control). Figure 3a -Pentose phosphate pathway; b) T cell receptor signaling; c) Insulin signaling, d) Oxidative phosphorylation, f)
antigen processing and presentation, g) Natural Killer cell cytotoxicity. FC -fold change. Each row on the Y axis represents a single gene probe and the
phylograms represent distinct signaling pathways. The red color denotes up regulated genes while the green are down regulated.
doi:10.1371/journal.pone.0030048.g003
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down-regulation of the insulin signaling pathway among the
HESN women. Though we could not, in our studies, directly
attribute the low expression of insulin genes to DPP4, the
association of very high DPP4 with diabetes is a confirmed
phenomenon [33,34]. DPP4 inhibits the incretin hormones,
glucagon-like peptide 1 and Gastric Inhibitory peptide, limiting
release of insulin from the pancreatic cells and inducing a
hyperglycemic state. Subsequently treatment protocols for type 2
diabetes have incorporated DPP4 inhibitors [35]. Though our
follow up studies affirmed high DPP4 expression at the protein
level [36], clinical evaluation of the HESN cohort did not confirm
type 2 diabetes but an impaired fasting glucose state. This suggests
that development of type 2 diabetes nay not be an automatic
phenomenon in this cohort. We are carrying out further functional
studies to determine the probable contribution and mechanism of
DPP4 and insulin repression in the HESN phenotype.
The phospatidylinositol pathway was a key impacted signaling
system among the HIV-1 resistant women (p,0.0001) This
pathway consists of a cellular family of kinases that are activated
by tyrosine phosphorylation and act as second messengers by
regulating the phosphorylation of other kinases, including the
ribosomal S6 kinases and the MAPK signaling network [37].
Because of its control of activation of many pathways, the inositol
pathway is a critical mediator of various cellular processes. Down
regulation of the phospatidylinositol system has been linked, to
among others, low insulin levels. Insulin is a key regulator of the
PI3K/AKT signaling system and insulin, through the insulin
receptor substrate (IRS-1), provokes a rapid increase in levels of
inositol phospholipids, PIP [38]. Additionally, PI3K was shown to
be a key member of the pathway and was required for insulin
induced glucose transport and glycogen synthesis. We postulate
that the down expression of key immune pathways and cell
adhesion molecule genes in our dataset may have been the result
of the switch down of the PI3/AKT pathway, due in part by
reduced insulin secretion. Furthermore evidence of direct effect of
phosphotidylinositol signaling on HIV-1 infection has been noted.
Francois et al [39], reported that inhibition of PI3K resulted in
absence of HIV-1 infection of CD4+ T cells and macrophages
with X4 and R5 pseudo typed viruses. Similarly Brown et al [40]
has shown that blocking phosphotidylinositol phosphate (a
substrate of P13K), with monoclonal antibodies inhibited HIV-1
infection by two HIV-1 primary isolates in human peripheral
blood mononuclear cells. Chugh and colleagues [41] have
demonstrated that blocking the PI3K/AKT pathway with Akt
inhibitors dramatically reduced HIV-1 production from virus-
infected macrophages. The implications of the observed down
regulation of the phospatidylinositol pathway may hence be direct
or through inhibition of HIV-1 dependency signaling events
requiring PIP modulation.
In concordance with earlier findings from our group using
specific cell subsets [42], we also observed lower basal T-cell gene
expression, confirming a lowered immune activation state among
the HESN group. Immune activation has been suggested to be the
greater risk factor in HIV-1 infection and higher levels of activated
T-cells in sub-Saharan African populations have been associated
with higher HIV-1 prevalence [43]. This observation has been
supported further by evidence of decrease in T-cell activation with
Figure 4. Gene ontology (GO) for downregulated genes (4a) and upregulated genes among the HIV-1 exposed uninfected sex
workers.
doi:10.1371/journal.pone.0030048.g004
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phenomenon, or immune quiescence, proposes a mechanistic
profile of fewer activated cells presenting lesser targets to the AIDS
virus and making it easier to clear infections that occur. Our
findings of low basal gene expression in T-cells in our HESN
population is also concordant with reports from similar popula-
tions that have shown lower levels of activated T-cells among
seronegative partners of HIV-1 infected spouses [45]. Although
these observations contrasts with reports from others [46–49], the
gene expression patterns observed in our data bear a close
metabolic signature pattern to that of quiescent T cells. Activated
T cells have been noted to derive its ATP requirements from
cytoplasmic glycolytic pathway [50], whereas quiescent T-cells
derive metabolic needs through oxidative phosphorylation and
other catabolic processes in the mitochondria [51,52]. We noted
that one of the few gene expression pathways that was up
regulated by the HESNs was the mitochondrial oxidative
phophorylation pathway (OXPHOS) with a concomitant pro-
found down regulation of enzymes in the glycolysis pathway.
An up-regulation of DNA binding genes that have been
associated with gene editing and silencing was a key phenomenon
among the HESN. This included the Zinc finger (ZFN) and
SMAD proteins encoding genes. Among the highly expressed ZFN
genes were the Zinc Finger and Homeoboxes 2 (ZHX2) and Zinc
Finger protein 20 (ZBTB20). ZHX2 has been identified as a
transcription repressor gene [53] while ZBTB20 is a key repressor
of alpha fetoprotein gene transcription [54]. SMAD3 is a strong
enforcer of quiescence in T-lymphocytes through its antiprolifer-
ative and pro-survival signals [55]. In addition, the non-coding
gene Xist, reported to trigger chromosome-wide gene repression
[56], was highly up-regulated in the HESN women (p 2.80E
210).
In tandem with the overexpression of gene silencing factors at
the transcriptional level, we observed dramatic down regulation of
host factors reported to be important for successful HIV-1
infection. These factors included intergrins, a class of cell surface
receptors that mediate linkages with the extracellular matrix and
have been identified as HIV-1 receptors [57], catenins, compo-
nents of the actin cytoskeleton shown to enhance HIV-1 infection
by anchoring chemokine receptors CCR5 and CCR4 to the cell
membrane [58], and NF- kB a known modulator of immune
function that directly enhances HIV-1 transcription at the proviral
level [59].
A previous in vitro genomewide screen identified more than 273
host genes that were essential for HIV-1 infection [60]. We noted
that 66 of the genes identified in that study were among those
differentially regulated by the HIV-1 resistant women at significant
levels, most of which (61%) were down regulated (data not shown).
Our findings imply that a repertoire of genes acting in concert
rather than a single determinant may be responsible for the
observed HESN phenotypes in the Pumwani cohort. Our data
also suggest that genes contributing to a lowered basal immune
activation state, in tandem with a general repression of host HIV-1
dependency factors, may be a key contributor to the HIV-1
resistance phenomenon. Hence, the understanding of signaling
and metabolic events that regulate immune activation may
provide crucial information for the design of effective anti-HIV-
1 preventive strategies.
Materials and Methods
Ethical Statement
This study was guided by the Helsinki Declaration on ethical
principles for medical research involving human subjects. All
studies were approved by University of Nairobi/Kenyatta
National Hospital Ethical Review Board and the University of
Manitoba Health Research Ethics Board. All patients provided
written informed consent for collection of samples and subsequent
analysis.
Subjects
The Nairobi (Pumwani) commercial sex worker cohort was
established in 1985 and has provided vital data that there might be
biological mediated resistance to HIV-1 infection [11,16,20,21].
Despite repeated exposures to HIV-1, a number of women in this
cohort have remained HIV-1 uninfected for long periods of time
and have been epidemiologically defined as HIV resistant [20].
Resistance has not been linked to frequency and duration of
Table 1. Expression patterns of genes previously reported to
be associated with HIV-1 Resistance.
Gene Regulation Fold Change p value Reference
APOBEC3G up 1.1 0.7 [19]
CCL3L1 up 1.2 0.4 [65]
CCL4 up 1.1 0.6 [19]
CCL5 down 21.1 0.6 [19]
CCR5 down 21.1 0.6 [14]
CD207(Langerin) up 1.2 0.4 [66]
CD209(DC-SIGN) down 21.2 0.02 [67]
CUL5 up 1.3 0.2 [68]
CXCL12(SDF-1) down 21.2 0.6 [69]
DEFA1 up 1.3 0.4 [71]
DEFA3 up 1.3 0.4 [71]
DEFB1 up 1.4 0.001 [15]
DEFB4 up 1.2 0.5 [15]
HLA-A down 21.1 0.01 [16]
HLA-B down 21.1 0.04 [16]
HLA-C down 21.1 0.03 [16]
IL4 down 21.1 0.9 [70]
KIR2DL1 down 21.9 0.02 [18]
KIR2DL2 down 21.7 0.01 [18]
KIR2DL3 down 21.8 0.07 [18]
KIR2DL4 down 21.6 0.02 [18]
KIR2DL5 down 21.6 0.02 [18]
KIR2DS1 down 21.5 0.2 [18]
KIR2DS2 down 21.8 0.1 [18]
KIR2DS3 down 22.2 0.04 [18]
KIR2DS4 down 21.6 0.1 [18]
KIR2DS5 down 22.03 0.02 [18]
KIR3DL1 down 21.9 0.01 [72]
KIR3DL2 down 21.8 0.02 [72]
KIR3DL3 down 21.8 0.08 [72]
PPIA(CyclophilinA) up 1.5 0.002 [24]
TRIM5alpha down 21.6 0.1 [15,17]
TSG101 down 21.1 0.3 [15]
TLR2 down 21.04 0.7 [73]
TLR4 down 21.2 0.07 [73]
TLR8 down 21.4 0.001 [73]
doi:10.1371/journal.pone.0030048.t001
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30048Table 2. Top 50 novel genes identified by microarray analysis with a fold change expression of 2 and above between the HESN
and control group.
Affymetrix ID Entrez Gene Symbol Chromosome Regulation pvalue
237953_at 1803 Dpp4 Chr2 up 1.99E-08
1569312_at 7705 ZNF146 Chr19 up 1.17E-07
237051_at 10463 SLC30A9 Chr4 up 1.27E-07
1559848_at 387338 NSUN4 Chr1 up 2.23E-05
241798_at 23244 SCC-112 Chr4 up 2.23E-05
244515_at 5713 PSMD7 Chr16 up 2.37E-05
243683_at 9643 MORF4L2 ChrX up 2.91E-05
1557575_at 8987 GENX-3414 Chr4 up 3.09E-05
232279_at 23338 PHF15 Chr5 up 4.94E-05
233127_at 55422 ZNF331 Chr19 up 4.93E-05
225354_s_at 83699 SH3BGRL2 Chr6 down 5.32E-05
223683_at 84225 ZMYND15 Chr17 down 6.42E-05
212667_at 6678 SPARC Chr5 down 6.57E-05
242191_at 200030 NBPF11 Chr1 up 6.60E-05
233302_at 64919 BCLIIB Chr14 up 7.06E-05
206494_s_at 3674 ITGA2B Chr17 down 1.01E-04
213258_at 7035 TFP1 Chr2 down 1.01E-04
221942_s_at 2982 GUCY1A3 Chr4 down 1.01E-04
201108_s_at 7057 THBS1 Chr15 down 1.41E-04
207114_at 80740 LY6G6C Chr6 down 1.72E-04
227088_at 8654 PDE5A Chr4 down 1.77E-04
1559126_at 23223 RRP12 Chr10 up 1.83E-04
216580_at 120872 RPL7 Chr12 up 2.08E-04
215859_at 56926 NCLN Chr19 up 2.20E-04
240263_at 51106 TFB1M Chr6 up 2.62E-04
227461_at 85439 STON2 Chr14 down 2.63E-04
201059_at 2017 CTTN Chr11 down 2.69E-04
1560043_at 51706 CYB5R1 Chr1 up 2.79E-04
202729_s_at 4052 LTBP1 Chr2 down 3.04E-04
230014_at 51646 YPEL5 Chr2 up 3.18E-04
236841_at 374666 FAM39DP Chr15 up 4.28E-04
239805_at 9058 SLC13A2 Chr17 down 4.75E-04
232570_s_at 80332 ADAM33 Chr20 up 6.13E-04
233087_at 64839 FBXL17 Chr5 up 6.13E-04
202275_at 2539 G6PD ChrX down 6.13E-04
229991_s_at 94121 SYTL4 ChrX down 6.24E-04
230945_at 10120 ACTRIB Chr2 up 6.80E-04
1558975_at 124402 FAM100A Chr16 up 6.86E-04
1552750_at 117286 CIB3 Chr19 up 6.94E-04
209676_at 7035 TFP1 Chr2 down 7.28E-04
206254_at 1950 EGF1 Chr4 down 1.10E-04
226303_at 5239 PGM5 Chr9 down 1.33E-03
205524_s_at 1404 HAPLN1 Chr5 down 1.36E-03
222319_at 4676 NAP1L4 Chr11 up 1.41E-03
205409_at 2355 FOSL2 Chr2 down 1.46E-03
200785_s_at 4035 LRP1 Chr12 down 1.50E-03
212077_at 800 CALD1 Chr7 down 1.62E-03
219232_s_at 112399 EGLN3 Chr14 down 1.79E-03
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exposure rates [21] In this study, sex workers who had been
followed up for more than 7 years and continue to be HIV-1
uninfected were included. As a control, samples were obtained
from an age-matched low risk HIV-1 negative group of non-
pregnant women in a monogamous relationship attending a
maternal and child health (MCH) clinic To control for
confounding effects due to sex work, the outcome was validated
against samples from a group of HIV negative sex workers who
were recently enrolled in the cohort (New Negatives) and had not
met a definitive stage for HESN.
Sample collection and processing
Whole blood samples were collected in PaxGene blood tubes
(Preanalytix, GMBH) and total RNA was extracted in Nairobi
following the manufacturer’s protocol (Qiagen). Briefly, pelleted
nucleic acids were digested with proteinase K then shredded
through a spin column to remove protein debris. The resulting
supernatant was mixed with ethanol and RNA was selectively
bound to a silica-based fibre matrix. Elution of RNA was done
with RNASE-free water after washing with saline buffers and
digestion with DNAse to remove DNA contamination. Assessment
of RNA quality, integrity and purity were done through a
Bionalyser 2100 (Agilent Technologies, Palo Alto CA). RNA
Samples were considered for further analysis only if they had
distinct 28 s and 18 s ribosomal peaks and had been processed or
frozen at 270uC within 5 hours after collection.
Microarray analysis
RNA samples meeting the above criteria were shipped to The
Centre For Applied Genomics, Hospitals for Sick Children,
Toronto for analysis. 100 ng of RNA was amplified using the
Affymetrix two cycle amplification kit (Affymetrix, Santa Clara,
CA) incorporating the Ambion MEGAscript T7 amplification
procedure. To minimize the challenges posed by abundant globin
RNA transcripts, Nugen Whole Blood Solution (Nugen, San
Carlos, CA) procedures were incorporated into the Affymetrix
protocol. Amplification, labeling, hybridization onto the Affyme-
trix U133 Plus 2.0 Gene Chip, washing, and scanning were
performed as per the manufacturer’s protocol.
Expression analysis
Background subtraction and probe signal summarization was
analyzed using the R Bioconductor software. The resulting log2
signal values were retransformed to linear scale and analyzed using
the Affymetrix MAS5 package. The program’s algorithm output
files represented the differences in intensities between the perfect
match and mismatch probe sets or a detection of present, marginal
or absent calls. Raw image DAT data was processed to CEL files
and analyzed using the ArrayAssist software (Stratagene, La Jolla
CA). The ratio of the geometric means of the expression analysis of
the relevant gene fragments was computed to yield a fold change
analysis. Confidence intervals and corrected p values were
calculated using a Rank Wilcoxson test. Significance was assessed
using a 0.5 threshold of the false discovery rate (FDR) which
Affymetrix ID Entrez Gene Symbol Chromosome Regulation pvalue
1569542_at 166647 GP125 Chr4 up 1.90E-03
200661_at 5476 CTSA Chr20 down 2.00E-03
doi:10.1371/journal.pone.0030048.t002
Table 2. Cont.
Figure 5. Outcome of a comparative quantitative RTPCR validation on randomly selected genes from the microarray analysis. Genes
expression profiles from HESNs were compared with HIV uninfected non sex worker maternal child health clinic attendees (HIV negative) and HIV
Negative new entrants into the sex trade (New Negatives). Each assay was a ratio gene quantity to its 18srRNA. G6PDH- glycose 6 phospate
dehydrogenase; G3PDH-Glyceraldehyde 3 phosphate dehydrogenase; PGM-1-Phosphoglucomutase-1; IRS-1-Insulin receptor substrate-1; ZNF346-
Zinc finger nuclease 346; ZHX2- Zinc finger and homeodomain protein 2.
doi:10.1371/journal.pone.0030048.g005
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the HESN and controls .1.3 fold and p value ,0.05 and called as
present in at least 50% of the samples tested were considered as
differentially expressed. Heatmaps showing differential expression
were generated using R and Bioconductor Software [61]. The
Database for Annotation, Visualization and Integrated Discovery
(DAVID) [62,63] was used for pathway analysis of the significantly
expressed genes.
Real Time PCR
Selected array results from HESN and controls were validated
by quantitative PCR using LightCycler real time PCR (Roche
Diagnostics). And to asses that the gene expression profiles may
not have been confounded by sex work, blood samples from sex
worker women who have been involved in sex work for one year
and were HIV negative (New Negatives) were randomly selected
and included as additional controls in qRT-PCR confirmation of
microarray data.
Samples were analysed with Quantitect SYBR Green RT PCR
assay kit as per the manufacturer’s protocol (Qiagen). Briefly,
100 ng of each sample were ran in duplicate and normalized to 18
sRNA. Relative expression of each gene was determined from a
standard curve of pooled cDNA from human peripheral blood
mononuclear cells with total RNA extracted in the same way in a
10 series dilution to form the qRT-PCR standards [64]. p-values
for significance were analyzed using a student t-test.
GeneBank. The microarray data have been deposited at the
Genomic Spatial Event (GSE) database under numbers GSE
30155–30240 and GSE 33580.
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